Oncternal Therapeutics: Q1 Earnings Insights

Oncternal Therapeutics ONCT reported its Q1 earnings results on Thursday, May 4, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Oncternal Therapeutics reported in-line EPS of $-0.2 versus an estimate of $-0.2.

Revenue was down $543 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 15.37% drop in the share price the next day.

Here's a look at Oncternal Therapeutics's past performance:

To track all earnings releases for Oncternal Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.